New England Biolabs (United States)
New England Biolabs is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
76%
Total
Publications
1.7K
Total Open
Publications
1.3K
Total
Citations
98K
Open Access
Percentage
76%
Total
Publications
1.7K
Total Open
Publications
1.3K
Total
Citations
98K
Breakdown
Publisher Open
9%
Both
47%
Other Platform Open
20%
Closed
24%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 50%
485
Hybrid 30%
292
No Guarantees 20%
197
Other Platform Open
Domain 87%
1K
Institution 21%
244
Public 17%
199
Preprint 13%
147
Other Internet 11%
131
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1K |
Europe PMC | Domain | 832 |
Semantic Scholar | Public | 184 |
bioRxiv | Preprint | 115 |
DOI | Other Internet | 53 |
Harvard University - Digital Access to Scholarship at Harvard (DASH) | Institution | 47 |
Research Square | Preprint | 30 |
Unknown Repository | Other Internet | 28 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 26 |
University of Edinburgh - Edinburgh Research Explorer | Institution | 24 |